leukoerythroblastic smear

A leukoerythroblastic smear is a peripheral blood finding characterized by the premature release of immature myeloid precursors (promyelocytes, myelocytes, metamyelocytes) and nucleated red blood cells (normoblasts/erythroblasts) into circulation, typically accompanied by teardrop-shaped red cells (dacrocytes). This pattern reflects disruption of the normal bone marrow architecture, either through space-occupying infiltration or severe marrow stress, causing extramedullary hematopoiesis to occur in the spleen and liver, which releases these immature cells prematurely.

Causes fall into two main categories: 1. Myelophthisic processes - marrow replacement/infiltration by: primary myelofibrosis (classic cause), metastatic carcinoma (breast, prostate, lung), hematologic malignancies (leukemia, lymphoma, multiple myeloma), granulomatous diseases (TB, sarcoidosis), and storage diseases (Gaucher disease). 2. Severe marrow stress - seen in severe hemolytic anemia, severe hemorrhage, overwhelming sepsis, or hypoxia, where the marrow releases cells prematurely to compensate.

Clinically, this finding should prompt further workup including bone marrow biopsy (often showing a 'dry tap' in myelofibrosis due to fibrosis), imaging for malignancy, and assessment for hepatosplenomegaly (from extramedullary hematopoiesis). The combination of teardrop cells, nucleated RBCs, and immature granulocytes is a key board-testable triad suggesting marrow fibrosis or infiltration rather than a primary blood disorder. It differs from leukemoid reaction in that leukoerythroblastosis includes nucleated RBCs, which are typically absent in a reactive leukocytosis.